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PEMBINAAN DAN PENCIRIAN MUTAN DELESI wzm  






Dalam Burkholderia pseudomallei, patogen yang menyebabkan ‘melioidosis’, kumpulan 
kluster gen yang berfungsi mengekod polisakarida kapsul tersebut terletak pada 
kromosom pertama. Secara keseluruhannya, terdapat sejumlah 22 gen pada kluster ini 
dan di kalangan gen-gen kapsul dalam gen kluster ini, gen wzm masih tidak dikaji secara 
keseluruhan. Jujukan asid amino gen wzm menunjukkan similariti yang tinggi terhadap 
CtrC (Neisseria Meningitidis), BexB (Haemophilus Influenzae) dan KpsM (Escherichia 
coli). Untuk mengkaji fungsi gen wzm, mutan isogenik gen wzm dibentuk dan 
dianalisiskan secara in vitro serta dibandingkan dengan strain jenis liar. Daripada 
penemuan yang didapati, mutan menghasilkan kurang biofilm berbanding dengan strain 
jenis liar. Selain itu, mutan lebih sensitif terhadap pengeringan dan stres oksidatif 
daripada strain jenis liar. Namun, tiada perbezaan yang signifikan dilihat untuk kedua-
dua mutan dan strain jenis liar dalam sensitivi terhadap osmolariti dan keadaan acid. Di 
samping itu, mikroskopi elektron penskanan menunjukkan permukaan sel-sel bakteria 
mutan didapati “kasar” berbanding dengan strain jenis liar. Akan tetapi, tiada perbezaan 
fenotip dapat diperhatikan dengan mikroskopi elektron transmisi apabila sel-sel bakteria 





CONSTRUCTION AND CHARACTERIZATION OF A Burkholderia 




In Burkholderia pseudomallei,  a pathogen that causes melioidosis, the gene cluster that 
encodes for capsular polysaccharide are located in chromosome one. There are 22 genes 
in this cluster and among the capsular genes in the cluster, the wzm gene has not been 
studied thoroughly. The amino acid sequence of wzm shows high similarity to CtrC 
(Neisseria Meningitidis), BexB (Haemophilus Influenzae) and KpsM (Escherichia coli). 
To study the function of wzm gene, an isogenic mutant of wzm gene was generated and 
analyzed in comparison with the wild type strain. From the findings, the mutant 
produced less biofilm compared to the wild type strain. Furthermore, the mutant was 
more sensitive towards desiccation and oxidative stress than the wild type strain. 
However, no significant difference was observed for both mutant and wild type strains in 
their sensitivity towards high osmolarity and acid conditions. Moreover, scanning 
electron microscopy showed that the bacterial cells of the mutant strain have “rough” 
surface compared to the wild type strain. However, no phenotypic difference could be 
observed using transmission electron microscopy when both bacterial cells of both 







Burkholderia pseudomallei is a gram negative rod-shaped bacterium that causes 
melioidosis to both human and animals. Among the signs and symptoms that are caused 
by this disease in human are septicaemia and pneumonia (Cheng and Currie, 2005). 
Study on the pathogenesis of this fastidious bacterium has attracted the attention of 
scientists as melioidosis has been reported to be endemic in various parts of the world 
and B. pseudomallei was reported to be resistant to many antibiotics (Cheng and Currie, 
2005).  
 
To understand the molecular and cellular basis of pathogenesis of B. 
pseudomallei, many researchers had started to identify virulence determinants at both 
proteomic and genetic levels. Among the virulence determinants that were identified 
were phopholipase C (Korbsrisate et al., 1999), flagella (DeShazer, 1997) and 
lipopolysaccharide (DeShazer et al., 1998)  
 
Capsular polysaccharide which is one the virulence determinants in B. 
pseudomallei has the potential to be utitilized as a vaccine (Sarkar-Tyson et al., 2007). 
The genetic organization of capsular polysaccharide in B. pseudomallei has been 
identified by Reckseidler-Zenteno et al. (2001) and Holden et al. (2004). The functions 
of the genes that are located in the cluster were annotated by the latter. Previous studies 
have shown that capsular polysaccharide is involved in the virulence of B. pseudomallei 
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in Syrian hamster and mice (Reckseidler et al., 2001; Atkins et al., 2002; Cuccui et al., 
2007). Apart from these in vivo animal studies, the capsular polysaccharide may protect 
the B. pseudomallei from phagocytosis by reducing levels of complement C3 deposition.  
 
 It has been shown in previous studies that inactivation using signature-tagged 
mutagenesis of wzm gene had led to the decrease in survival in mice (Cuccui et al., 
2007). The wzm gene was chosen for this study among the genes in the capsular 
polysaccharide cluster as this gene was not well studied compared to the other capsular 
genes in the cluster. Hence, in this study, B. pseudomallei UKMS-01, a local animal 
isolate from sheep is used to investigate the role of wzm gene in harsh conditions.   The 
approach of this research is to construct a markerless and in-frame deletion of wzm 
mutant of B. pseudomallei and use a few in vitro studies which are osmotic stress assay, 
desiccation survival assay and biofilm formation assay to study the phenotypic 
characteristics of the ∆wzm mutant in comparison with the wild type strain. In addition, 
the sensitivity of ∆wzm mutant towards oxidative and acidic conditions is also 
investigated. Moreover, the surface and the internal structures of the bacterial ∆wzm 
mutant cells will be viewed using scanning and transmission electron microscopy to 
determine whether there are changes in cellular surface as well as the internal structures 









2.0 Literature review 
2.1 Burkholderia pseudomallei  
 
Burkholderia pseudomallei is generally classified as a gram negative, facultative 
anaerobic, motile and rod shaped bacteria (Wiersinga et al., 2006, Holden et al., 2004, 
Dance, 2002). It is formerly known as Bacillus pseudomallei or Pseudomonas 
pseudomallei, and is later re-named as Burkholderia pseudomallei in 1992 based on 16S 
rDNA sequence (Currie et al., 2004). Burkholderia pseudomallei has been documented 
by many researchers as a known causative agent of melioidosis, a disease that can cause 
acute illness in both humans and animals (Gilad et al., 2007). 
 
B. pseudomallei is motile, due to the existence of lophotrichous flagella 
(DeShazer et al., 1997). This bacterium has the ability to grow on various types of 
organic matters such as in carbohydrates, amino acids and fatty acids. At the same time, 
the morphology the B. pseudomallei colony can be positively identified although it may 
vary from rough to smooth wrinkled and may either show white or brown pigmentation 





C, with the optimum temperature being 37
o
C (Tong et al., 1996). Nevertheless, the 
B. pseudomallei has been shown to have a rapid growth curve at 42
0
C in the any growth 
medium and this in turn can cause a depletion or shortage of nutrients within 48 hours 
and will eventually form a layer of sediment on the plate.  
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The optimal pH for the growth of bacteria was reported to be in the range of pH 
5 to 8. It was also reported that rapid bacterial inactivation occurs when the pH is below 
4.5 (Tong et al., 1996). In addition, studies have shown that B. pseudomallei is able to 
survive when exposed to solutions with less than 2.5% of sodium chloride. However, the 
bacteria tend to be inactive when exposed to solutions that are more than 2.5% sodium 
chloride (Inglis and Sagripanti, 2006). This is opposed to the study done by Pumirat et 
al. (2009), which mentioned that B. pseudomallei can survive in a salty concentration of 
more than 2.5%. So far, no other studies were conducted on the survival rate of the 
particular bacteria in seawater but there were reports of melioidosis in survivors of the 
tsunami disaster that occurred on the 26
th
 December 2004. Those infected were believed 
to have directly contacted B. pseudomallei through their lungs by ingesting 
contaminated flood water supply (Chierakul et al., 2005). There were reports regarding 
the use of chlorine to treat drinking water to eliminate the B. pseudomallei. Studies 
conducted by Howard and Inglis (2003) showed that a concentration of 1000 ppm of 
chlorine can eradicate B. pseudomallei in drinking water. However, this may not be 
commercially viable as 1000 ppm of chlorine may cause more harm to human health 
instead. Furthermore, this bacterium can only survive for 7.75 minutes after exposure to 
UV light (Tong et al., 1996).  
 
The genome of B. pseudomallei strain K96243, a clinical isolate from Thailand 
had been sequenced and analysed by Wellcome Trust Sanger Institute, United Kingdom. 
B. pseudomallei has two main chromosomes, namely, chromosome 1 and chromosome 2 
which are 4.1Mb and 3.2Mb in size respectively (Holden et al., 2004). A large 
percentage of coding sequence in chromosome 1 has been associated with core functions 
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like cell growth and metabolism while chromosome 2 entails more extensive coding 
sequences that are involved in accessory functions such as survival and adaptation to the 
environment (Holden et al., 2004). In addition, the National Center for Biotechnology 
Information currently has listed another 20 genome sequences and among the 20, three 
were fully annotated. The three strains are strains 1106a, 1710a (Thai clinical isolates) 
and 668 (an Australian clinical isolate) (Adler et al., 2009). 
 
The genomic DNA of B. pseudomallei strain K96243 has 16 genomic islands 
that take up to 6% of the whole genome (Holden et al., 2004). Tumapa et al. (2008) 
demonstrated that there is variation in the presence of genomic islands among different 
B. pseudomallei isolates. However, the presence of a specific island does not correlate 
with the virulence of the isolate. The paper by Tumapa et al. (2008) presented only a 
few representative islands and strains. There is a possibility that other studies may 
identify striking differences in terms of genomic characteristics between clinical and 
environmental isolates. By performing phylogenetic studies, it was demonstrated that B. 
pseudomallei is not so closely related to B. thailandensis than to B. mallei. This 
suggested that the evolution of B. pseudomallei is more recent compared to other 
members of the Burkholderia genus (Ou et al., 2005).  
 
By comparing the genomic, transcriptional and proteomic levels of strain B. 
pseudomallei K96243 and B. pseudomallei 15682, there were significant intrinsic 
differences between both strains (Ou et al., 2005). From the data obtained, it was 
suggested that horizontal gene transfer or gene loss events had occurred as about 43% of 
the gene expression differences were associated with genes that are not present in one or 
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the other strain. Furthermore, about 38 % of the global proteomic differences were 
attributed to strain-specific isoforms of proteins expressed in these two strains (Ou et al., 
2005). These findings correlate with the results obtained in another two studies that 
observed the genome-wide variability between B. pseudomallei K96243 and 1026b 
strains (DeShazer, 2004) and between B. pseudomallei K96243 and B. mallei (Fushan et 
al., 2005). From all these findings gathered, it can be deduced that variation in 
phenotypes that are related to growth rate, environmental resistance and virulence may 




B. pseudomallei is reported to thrive through saprophytic means. It inhibits 
stagnant waters or soils, for example, in paddy fields or in flooded areas (Chaowagul et 
al., 1989). This explains why it was prevalent among rice farmers and helicopter pilots 
during the Vietnam War, as most of them were exposed to contaminated soil through 
ingestion and open wounds (Sanford, 1995). The bacterium was also found to be 
endemic in Thailand (Leelarasamee 2000), Malaysia (Puthucheary et al., 1992), 
Singapore (Chan et. al., 1985; Lim et al., 1997) and northern Australia (Cheng et al., 
2000; Currie et al., 2000). Besides that, sporadic cases were also reported in Southern 
Taiwan (Shih et al., 2009), North, Central and South America (Inglis et al., 2006), India 
(Saravu et al., 2008), Africa, the Caribbean, and the Middle East (Dance, 2000).  
 
Incidence of melioidosis that occurred in certain parts of the world, however, 
remains woefully unknown. This is especially in third world countries. This could be 
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due to the fact that some reported cases were poorly documented, under reported or even 
unreported due to limited resources and unsuitable facilities in some laboratories 
(Dance, 2002). 
 
2.3 Melioidosis  
 
One of the reasons why B. pseudomallei generated a world wide interest is due to 
the fact that it is a potential agent of melioidosis, which can indirectly cause a broader 
spectrum of chronic illnesses in both humans and animals alike (Gilad et al., 2007). A 
person could be infected easily by B. pseudomallei through simple means of ingestion of 
contaminated materials, open cuts or wounds, abrasions or even through inoculation of 
infected needles during laboratory experiments by researcher themselves (White, 2003). 
Once infected with B. pseudomallei, it may stay dormant in the host body for years 
without showing any obvious physical or bodily symptoms (Cheng and Currie, 2005). 
Examples of reported cases include cases of American soldiers who returned from the 
Vietnam War, only to start showing symptoms of melioidosis after 30 years. The 
mortality rate of melioidosis is high and relapses are not uncommon as the disease can 
affect almost every organ in the host body (Sanford, 1995). Up till now, there is still no 
vaccine for the prevention of B. pseudomallei infection and an infected person is likely 
to suffer from either acute septicaemia (blood poisoning) or pneumonia (lung infections) 
(Deshazer et al., 1998, Reckseidler et al., 2001). Wiersinga et al. (2006) also reported 
that this septicaemic form of melioidosis involves a rapid onset and death is inevitable 
usually during the first 12 to 24 hours.  
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Therefore, the incidence of melioidosis should not be taken lightly as it could 
spiral out of control as it can affect anyone. Furthermore B. pseudomallei has been 
classified as being a potential bio-agent to be used in future bioterrorism attacks. 
 
2.4 Melioidosis in animals 
 
 Melioidosis affects animals as much as human. So far, there have been reports 
showing that animals such as birds, dogs, goats, kangaroos, pigs, camels, horses, cats, 
rats and dolphins are being infected by melioidosis caused by B. pseudomallei (Cheng 
and Currie, 2005). Although there is still no incidence of melioidosis being transmitted 
from animals to humans, precautions have to be observed at all times. For example, face 
masks and gloves should be worn during handling of infected animals. Meanwhile, 
farmers should also be prudent and not hesitant to cull infected live stock though loss is 
expected as it may cause serious loss of human lives later on. 
 
2.5 Treatment of melioidosis 
 
 Treatment of melioidosis is challenging due to the fact that B. pseudomallei itself 
is resistant to certain antibiotics such as gentamicin and streptomycin (Chaowagul et al., 
1989). On top of that, it has also been reported that B. pseudomallei could survive in soil 
and water for many years, and therefore, must have a certain adaptive mechanism which 
allows them to continue to survive in harsh and stressful environments (Pumirat et al., 
2009). Proteomics studies conducted by Pumirat et al. (2009) showed the changes in 
protein secretions in B. pseudomallei under high salt (sodium chloride) concentration 
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stress. It was reported that bacteria induced with a high salt environment had a 19-fold 
increase in a beta-lactamase-like protein which render it resistant to beta-lactam 
antibiotics, and hence, increases its survival rate. 
 
Despite this, treatment of melioidosis is not impossible and the percentage of 
recovery increases with early detection and proper diagnosis. There were many cases of 
patients being successfully treated with various types of antibiotics and these include 
penicillins and cephalosporins (Cheng and Currie, 2005). Generally, the treatment would 
be conducted in two stages; the antibiotic being administered intravenously in multiple 
doses until the steady state of drugs in blood level is achieved. This would then be 
followed by giving the patients drugs orally to prevent further recurrence or relapse 
(Cheng and Currie, 2005).   
 
Current studies supporting successful treatments of melioidosis include a study 
conducted by Simpson et al. (1999), whereby ceftazidime or imipenem were 
administered intravenously, after the onset of the disease. Nevertheless, the easiest route 
of administration, the oral route, is still lacking data to support its effectiveness. Despite 
this, there are evidence in mice studies showing that animals administered with co-
trimoxazole as pre-exposure and post-exposure prophylaxis had longer survival rate, 
compared to the control group (without administration of antibiotics) and those 





2.6 Diagnosis of melioidosis 
 
To diagnose the incidence of melioidosis, an effective method is highly sought 
after for the fast delivery of correct dosage/ medicament to the infected patients. One of 
the most popular means to diagnose melioidosis is by utilizing the Ashdown medium 
(Ashdown, 1979). Ashdown medium is a highly selective medium that selects for B. 
pseudomallei. To carry this out, selective specimens were normally taken from patients’ 
blood, urine, sputum, throat or pus afflicted areas and were then cultured on 5% blood 
agar (usually horse blood agar) to isolate the bacteria. The medium is then observed 
through phenotypic means for the appearance of B. pseudomallei colonies. The method 
is simple but the drawback is that the medium is not commercially available and not 
rapidly obtainable for patients from non-endemic countries like the United States or in 
western countries (Inglis et al., 2006). Besides that, the procedure is also time 
consuming and may not be viable for clinically chronic patients (Kaestli et al., 2007; 
Chaowagul et al., 1989). Nevertheless, this method is still being used, and remains the 
‘gold standard’ in diagnosing melioidosis due to its relative cheap cost and high 
efficacy.  
 
A unique monoclonal antibody (Mab) which is specific to the 30-kDa protein of 
B. pseudomallei has been developed by Pongsunk et al. (1999). The specific monoclonal 
antibody has been proven in both in vitro and in vivo (mice) studies to directly 
agglutinate with 243 clinical isolates of the B. pseudomallei but not with other Gram 
negative bacteria except B. mallei. A closely related method involves a study in 
developing a rapid multiplex immunofluorescent assay method to detect antibodies 
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against B. pseudomallei. The method will detect antibodies against the 
lipopolysaccharide (LPS) layer of B. pseudomallei should they be present in the obtained 
clinical samples (Iihara et al., 2007). 
 
There are various publications on molecular methods for the detection of B. 
pseudomallei. These methods involved PCR analysis of primers targeting regions in 16S 
and 23S rRNA genes, 16S-23S intergenic region, flagellin gene fliC and Type III 
secretion gene cluster (Lew and Desmarchelier, 1994; Dharakul et al., 1996; 
Bauernfeind et al., 1998; Gal et al., 2005; Merritt et. al., 2006). PCR-based method is 
reported to be accurate and produces fewer discrepancies in diagnosing melioidosis 
(Merritt et al., 2006). Apart from the normal PCR methods, some scientists has 
evaluated real-time PCR to obtain more reliable and rapid results (Meumann et al., 
2006; Novak et al., 2006; Supaprom et al., 2007).  
 
2.7 Virulence determinants of Burkholderia pseudomallei 
 
The huge magnitude of the disease caused by this pathogen may imply that this 
bacterium utilizes a broad range of virulence factors as means of survival in the infection 
of animals. It is therefore essential to investigate the roles of virulence factors to 
understand the pathogenesis of B. pseudomallei. To date, the virulence factors in this 
fastidious bacterium are currently understudied compared to other pathogenic bacteria. 
Elucidation of these virulence determinants in B. pseudomallei is currently the main 
focus of study in the scientific community. A better understanding of these virulence 
factors can form a rational basis in producing novel vaccines and therapies in curing 
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melioidosis. The completion of B. pseudomallei K96243 genome sequencing by Sanger 
Institute, genomic sequencing analysis using bioinformatics and the development of 
genetic tools had facilitated identification and isolation of putative virulence factors 
(Holden et al., 2004; Reckseidler-Zenteno et al., 2003). Genetic techniques that were 
used in identifying genes associated with virulence factors include Tn5 transposon 
mutagenesis (DeShazer et al., 1997; Burtnick, et al., 2001), counter-selection markers 
that facilitate allelic exchange (Moore et al., 1999; Brown et al., 2004; Burtnick and 
Woods, 1999, Lopez et al., 2009) and signature-tagged mutagenesis using animal 
infection models (Atkins et al., 2002, Moore et al., 2004). Apart from the reported 
genetic manipulation methods, subtractive hybridization was also introduced in search 
for novel virulence factors (Brown and Beacham, 2000; Reckseidler et al., 2001). 
  
In order to study the virulence factors in B. pseudomallei, animal models had 
been developed. These animal models include BALB/c mice (Leakey et al., 1998; 
Hoppe et al., 1999; Liu et al., 2002; Jeddeloh et al., 2003;), Syrian hamster (Brett et al., 
1997), diabetic rats (Woods et al., 1993), guinea pigs (DeShazer et al., 1998), pigs 
(Najdenski et al., 2004) and Caenorhabditis elegans (O’ Quinn et al., 2001; Gan et al., 
2002). 
The diabetic rat model using intraperitonal route of infection was devised 
following the correlation of diabetes mellitus and melioidosis (Woods et al., 1993). This 
model had been used by many researchers to study a number of putative B. pseudomallei 
virulence factors with some success (Sexton et al., 1994; DeShazer et al., 1997; Jones et 
al., 1997; DeShazer et al., 1998).  DeShazer et al. (1998) also utilized guinea pig as an 
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animal model by using intraperitonal route of infection to compare the 
lipopolysaccharide mutants with the wild type B. pseudomallei 1026b strain. However, 
there is no subsequent use of guinea pigs in any literature reported for the study of 
virulence determinants. Brett et al. (1997) had reported that Syrian hamster were highly 
susceptible to B. pseudomallei when the animal was infected via intraperitonal route 
with an LD50 <10 CFU. Subsequent studies had reported the use of Syrian hamster to 
study the putative virulence factors (DeShazer et al., 1997; Jones et al., 1997; DeShazer 
et al., 1998; DeShazer et al., 1999; Moore et al., 1999; Reckseidler et al., 2001; Ulrich 
et al., 2004, Warawa and Woods, 2005). 
With the employment of genetic tools and animal studies, a number of virulence 
determinants were identified. The identified virulence factors that are involved in the 










Table 2.1 : List of virulence factors that are identified in B. pseudomallei (Adapted 
from Adler et al. (2009) 
Virulence factors References 
Capsule  Reckseidler-Zenteno et al. (2005) 
Lipopolysaccharide (LPS) DeShazer et al. (1998); Burtnick and 
Woods (1999) 
Flagella DeShazer et al. (1997); Chua et al. (2003); 
Chuaygud et al. (2008) 
Type III secretion systems (Bsa) Stevens et al. (2002); Boddey et al. (2006) 
Quorum Sensing Valade et al. (2004); Song et al. (2005); 
Lumjiaktase et al. (2006) 
Pili Essex-Lopresti et al. (2005); Brown et al. 
(2002); Boddey et al. (2006) 
Efflux pumps Chan and Chua (2005) 
Siderophore Loprasert et al. (2000) 
Exoproducts*  DeShazer et al.(1999); Gauthier et al. 
(2000) 
Morphotype switching Chantratita et al. (2007) 
 
*Exoproducts are secreted factors which are proteases, lipases, lecithinases and 





2.7.1 Secreted Antigens 
The identified extracellular virulence factors are thermolabile toxin, protease, 
antigens with lipase and lecithinase activities, haemolysin and water soluble 
siderophore. Although these putative virulence factors were identified, they are not well 
characterized. 
Several studies that were published between the years 1955 and 1964 indicated 
that intraperitoneal (i.p.) injections of filter sterilized B. pseudomallei supernatants were 
lethal to both mice and hamsters. This experiment had suggested that B. pseudomallei 
produce a lethal toxin (Nigg et al., 1955). Ismail et al. (1987) later had partially purified 
a 31 kDa thermolabile toxin. This protein was shown to be able to inhibit DNA and 
protein synthesis, and to be lethal in mice. However, subsequent researchers were unable 
to reproduce this finding using filter sterilized B. pseudomallei culture to test on animal 
models (Brett and Woods, 2000). 
Haase et al. (1997) had identified another cytolethal toxin (CLT) in B. 
pseudomallei and the isolates from goat and patients with melioidosis encephalitis 
produced higher toxin as compared to the isolates from soil. Furthermore, Haubler et al. 
(1998) demonstrated that a 762 Da heat-stable toxin produced cytotoxic effects on 
phagocytic (HL60) and non-phagocytic (HeLa) cell lines. This toxin showed haemolytic 
activity when incubated with erythrocytes (Haubler et al., 1998). O’Quinn et al. (2001) 
and Gan et al. (2002) had conducted studies using C. elegans which suggested that toxin 
produced by B. pseudomallei failed to have deleterious effect on this model organism. 
These findings were supported by Balaji et al. (2004) whereby filter sterilized B. 
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pseudomallei supernatants did not kill the worms but live bacteria were lethal to C. 
elegans. Even though B. pseudomallei had been shown to produce exotoxins, there were 
no reports on characterization of these toxins at the molecular level. 
Apart from toxins, B. pseudomallei was shown to secrete biologically active 
proteins such as hemolysin, protease, lipase and lecithinase (Ashdown and Koehler, 
1990) and iron-acquiring siderophores (Yang et al., 1991). Protease and lipase as 
secreted antigens were further demonstrated by Sexton et al. (1994) and Korbsrisate et 
al. (1999) respectively by purifying and characterizing these proteins. DeShazer et al. 
(1999) generated mutants with complete loss of protease, lipase and lecithinase activities 
using transposon mutagenesis system. From the results obtained, the type II general 
secretory pathway (GSP) gene cluster was identified but no structural genes of protease, 
lipase or lecithinase were identified (DeShazer et al., 1999). There was no significant 
difference between the generated mutants and wild type in terms of virulence when the 
B. pseudomallei GSP mutant was tested on Syrian hamsters (DeShazer et al., 1999).  
There are many reports in identifying proteases in B. pseudomallei. Among them 
are the studies conducted by Sexton et al. (1994). The findings revealed a purified 36 
kDa metalloprotease showing optimal activity at 60
o
C and pH 8 (Sexton et al., 1994).  A 
few years later, a 47 kDa B. pseudomallei serine metalloprotease designated as MprA 
was characterized by Lee and Liu (2000). N-terminal sequence of the protease that was 
purified by Sexton et al. (1994) existed in the predicted amino acid sequence of MprA, 
thus suggesting that these two proteins were the same proteases (Sexton et al., 1994; Lee 
and Liu, 2000). Valade et al. (2004) demonstrated that ∆mprA mutant did not show any 
reduction in survival in mice via intraperitoneal and intranasal routes of entry and this 
 17 
indicated that MprA was not a virulence determinant in mice (Valade et al., 2004). In 
2001, a serine metalloprotease with 52 kDa in size that was characterized by Ling et al. 
(2001) was highly dependent on calcium ions and showed optimal activity at 38
o
C and 
pH 9. This 52 kDa metalloprotease was able to digest immunoglobulins, transferring, 
albumin, myosin and actin (Ling et al., 2001). Gautheir et al. (2000) reported that there 
was no correlation between protease production in B. pseudomallei and virulence in 
BALB/c mice. Based on the findings by Gautheir et al. (2000) and DeShazer et al. 
(1999), it is suggested that exoproducts that are protease, lipase and lecithinase play a 
minor role in B. pseudomallei pathogenesis. 
  Based on the bioinformatic analysis of the B. pseudomallei K96243 genomic 
sequence, three phospholipase C (PLC) enzymes were identified and designated as PLC-
1, PLC-2 and PLC-3 (Holden et al., 2004). The enzymes PLC-1 and PLC-2 were acidic 
in nature and were able to hydrolyse lipids, phosphatidylcholine (PC) and 
sphingomyelin (Korbsrisate et al., 2007). It had been demonstrated that ∆plc-1, ∆plc-2 
and a double knockout ∆plc-1 plc-2 mutants showed decrease in PC-PLC activity 
(Korbsrisate et al., 2007). Thus, this indicated that these genes encoded functional 
enzymes. However, there was no complete loss of PC-PLC activity, suggesting that 
PLC-3 was also likely to be functional. In addition, Tuanyok et al. (2006) demonstrated 
that the virulence of ∆plc-3 mutant had decrease in hamsters. The ∆plc-3 gene was 
shown to be highly upregulated in comparison to its expression in in vitro grown 
bacteria when DNA microarray analysis was used to analyse B. pseudomallei isolated 
from hamsters (Tuanyok et al., 2006). Moreover, PC-PLC which was in vivo expressed 
in E. coli can induce IgM antibody production in patients with melioidosis using 
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Western blotting (Korbsrisate et al., 1999). Hence, this indicates that this lipase might be 
involved in intracellular survival and cell-to-cell spread of B. pseudomallei in the host 
(Korbsrisate et al., 1999). 
Ashdown and Koehler (1990) managed to identify two hemolysins after 
assessing hemolytic activities of 100 B. pseudomallei strains. Among the 100 strains, 4% 
of the strains had high hemolytic activity on sheep blood agar plates while the rest 
demonstrated low hemolytic activity (Ashdown and Koehler, 1990). In 2007, three ATP-
binding cassette transport systems that were involved in exporting hemolysins were 
predicted from B. pseudomallei K96243 genome (Harland et al., 2007). To date, the 
roles of hemolysin are still not clear. Hence, characterization in the molecular level is 
important to understand the virulence of B. pseudomallei. 
2.7.2 Cell-walled  associated antigens 
Besides secreting antigens as part of its strategy to impose virulence on other 
organisms, the B. pseudomallei is also known to produce cell-walled associated antigens 
such as flagella, pili, LPS and EPS. The flagella has long been hypothesized by many to 
be important to B. pseudomallei as it renders the cell motile and therefore, enabling it to 
move around freely in search of a conducive environment to thrive and spread virulence. 
Thus, Vorachit et al. (1995) has proven the existence of flagella and shown the variable 
expression of pili on B. pseudomallei by using electron microscopy. Furthermore, 
DeShazer et al. (1997) had identified 19 unique genetic loci that aid motility by 
performing mutagenesis. Bioinformatic analysis of B. pseudomallei K96342 genome 
further the identification of 13 gene clusters that are responsible for the synthesis of type 
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I fimbriae, type IV pili and Tad-like pili (Adler et al., 2009). The synthesis of a 39.1 kDa 
flagellum protein is controlled by fliC gene (DeShazer et al., 1997). There are 
conflicting evidences on the involvement of flagella towards virulence. 
Studies conducted by DeShazer et al. (1997) and Wikraiphat et.al (2009) showed 
that ∆fliC B. pseudomallei 1026b transposon mutant failed to reduce virulence in 
BALB/c mice as compared to the wild type when the diabetic rat or Syrian hamster was 
infected through the intraperitoneal route. However, Chua et al. (2003) showed that B. 
pseudomallei KHW ∆fliC mutant reduce in survival through intranasal or intraperitoneal 
routes in BALB/c mice but not in the C. elegans model of infection. The factors that 
contribute to the conflicting data are the usage of different animal models, different 
modes of infection and different types of mutants generated.  
As mentioned earlier, B. pseudomallei has also been reported to have structure 
on its surface known as pili. There are eight type IV pili-associated loci in the B. 
pseudomallei K96243 genome but only one type IV A pilin gene, pilA, exists on the 
genome (Essex-Lopresti et al., 2005).  B. pseudomallei strain K96243 pilA mutant 
demonstrated reduced adhesion to epithelial cell lines and reduced virulence in C. 
elegans animal model and in BALB/c mice that were infected through intranasal route 
but not intraperitoneal route (Essex-Lopresti et al., 2005). Studies that were conducted 
by Boddey et al. (2006) showed that two B. pseudomallei ∆pilA mutants generated in 
strains 08 and K96243 had variation in in pilA expression, microcolony formation and 
cell adhesion. Nevertheless, pilA expression in strain 08 mutant was temperature 
regulated and is important for microcolony formation expression of pilA in strain 08 
mutant was also not essential for adhesion to cultured human cells (Boddey et al., 2006).   
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Meanwhile, the LPS of the B. pseudomallei consists of 2 types of O-
polysaccharides, which is aptly named as type I-OPS and type II O-PS (Perry et.al, 
1995). B. pseudomallei mutants without the type II O-PS was shown to be susceptible to 
30% human serum killing through the bactericidal activities (DeShazer et al., 1998). In 
2006, a further identification of type III O-PS and type IV O-PS has been reported 
(Sarkar-Tyson et.al, 2007). Mice which were challenged with type III O-PS and type IV 
O-PS mutants showed increased mean times to death (approximately 11.6 days) as 
compared to those challenged with the wild type (3 days). Moreover, immunization with 
all polysaccharide mutant strains also resulted in delayed time to death, compared to the 
control group (Sarkar-Tyson et al., 2007). 
Another type of cell-walled associated antigen of B. pseudomallei is the 
exopolysaccharide (EPS). Up to date, there are a number of studies which identified the 
presence of these structures. One of the more well known EPS, a linear tetrasaccharide 
repeating galactose units, was shown to exist only in B. pseudomallei and not in B. 
thailandensis (Kawahara et al., 1998; Masoud et al., 1997; Steinmetz et al., 1995). Since 
B. thailandensis does not cause virulence, it is then suggested that the EPS plays a role 
in causing virulence. 
 
2.8 Burkholderia pseudomallei capsular polysaccharide 
   
The polysaccharide capsule is the structure that encapsulates and ‘surrounds’ the  
outer-most layer of the bacterium. It interacts with the existing environment and 
therefore, plays an important role in protecting the bacterium from harsh conditions as 
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well as to give rise to causing virulence in other living beings. 
 
B. pseudomallei extracellular polysaccharide has been classified into 2 major 
categories, (a) capsular polysaccharides (CPS), the polysaccharide closely in contact 
with the bacteria cell and (b) slime polysaccharides which is loosely associated with the 
cell respectively (Whitfield, 1995). It is difficult to differentiate between both types 
since CPS may sometimes resemble the slime polysaccharides when they are being 
‘released’ from the particular cell (Whitfield, 1995). Moreover, CPS also contains 
lipopolysaccharides (LPS) which are similar to other types of polysaccharides found on 
the surface of the cell (Whitfield, 1995). 
 
2.8.1 Roles of bacterial capsule in Burkholderia pseudomallei 
Bacterial capsule in each pathogenic bacterium has its own function(s). Although 
the role of capsular polysaccharide in B. pseudomallei is still not satisfyingly clear, the 
capsule basically helps the bacteria in terms of survival as well as to cause virulence.  
 
Previous studies have shown that capsular polysaccharide plays a vital role in 
virulence by using in vivo animal models such as hamsters and mice. Virulence studies 
conducted by Reckseidler et al. (2001) and Atkins et al. (2002) demonstrated that 
∆wcbB  and ∆wcbE mutants showed reduction in survival with more than 10
5
 fold when 
the mutants were exposed to hamsters and mouse models intraperitoneally and 
intraveneously. In addition to that, there were also studies that utilize signature tagged 
mutagenesis to identify genes from the capsule operon that were critical in causing 
diseases and virulence in mice (Cuccui et al., 2007). Inactivation of the genes wcbB, 
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wcbC and wcbN resulted in reduced survival of these mutants in mice (Cuccui et al., 
2007). More recently, Wikraiphat et al. (2009) did a comparative in vivo and in vitro 
analysis to determine the effects of 3 different types of B. pseudomallei mutants (without 
lipopolysacccharide, without capsule and without flagelin) in causing virulence in 
BALB/c mice and in both human polymorphonuclear cells (PMNs) and macrophages 
(Mфs). The lipopolysaccharide and capsule mutants, which were generated through 
molecular means, were reported to demonstrate a significant decrease in virulence in 
both mice models as well as in the presence of human PMNs and Mфs, suggesting that 
both lipopolysaccharide and capsule are highly associated with the virulence of the 
bacterium (Wikraiphat et al., 2009).  
 
On the other hand, there were also studies which indicated the importance of 
capsular polysaccharide in protecting the B. pseudomallei from host serum cidal activity 
and opsonophagocytosis by reducing levels of complement C3 deposition (Reckseidler-
Zenteno et al., 2005). Another similar study was conducted by Wikraiphat et al. (2009) 
in which the acapsular B. pseudomallei mutant was exposed to human PMNs and Mфs. 
The experiment showed a decreased level in bacteria residual numbers as compared to 
the wild type (with capsule), suggesting that without the presence of capsule, the 
bacteria is more susceptible to intracellular killing by the host’s defence systems. 
Besides that, Wikraiphat et al. (2009) also reported that the presence of the B. 
pseudomallei capsule provided a mediated resistance towards histatin and lactoferrin, 
suggesting that the capsule itself is important for the resistance towards certain 
antimicrobial peptides.  
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On top of that, B. pseudomallei capsular polysaccharide mutant has also been 
identified as a possible candidate for vaccine therapy (Sarkar-Tyson et al., 2007). Mice 
that were vaccinated with ∆wcbH mutants had higher levels of survival with 70% of 
mice surviving at day 35 as compared to mice that were vaccinated with wild type strain 
which showed 40% survivors (Sarkar-Tyson et al., 2007). Thus, this suggested that 
immunization with killed capsular polysaccharide mutant strains may confer immunity 
against B. pseudomallei.  
 
Other suggested functions of the bacterial capsule which have yet to be 
determined in B. pseudomallei include its involvement in the prevention of desiccation, 
adherence for colonization and resistance to specific host immunity (Roberts, 1996). 
 
2.8.2 Genetic organization of capsular polysaccharide gene cluster of B. 
pseudomallei  
 
According to the B. pseudomallei genomic sequence, the genes that are 
responsible for the synthesis and export of capsular polysaccharide in B. pseudomallei 
are located between nucleotides number 3327179 and 3359841 of the Chromosome 1 of 
B. pseudomallei K96243 (Holden et al., 2004). There are 22 genes altogether in this 
cluster (Figure 2.1). The functions of these genes were annotated by Sanger Institute as 
shown in table 2.2 (Holden et al., 2004). The capsular polysaccharide gene cluster was 
shown to have high percentage of similar in identity to the capsular clusters of other 
bacteria like Escherichia coli, Neisseria meningitidis and Haemophilus influenzae 






Figure 2.1: Genetic organization of B. pseudomallei K96243 capsular polysaccharide 
cluster. located at the sites 3327179 bp and 3359841 bp of the Chromosome 1 of B. 
pseudomallei K96243. This capsule cluster is approximately 30kb in size. Genes are not 
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